Applications for this meeting must be submitted by May 28, 2017. Please apply early, as some meetings become oversubscribed (full) before this deadline. If the meeting is oversubscribed, it will be stated here. Note: Applications for oversubscribed meetings will only be considered by the Conference Chair if more seats become available due to cancellations.
success of Mechanical Circulatory Support (MCS) is now supported by large multinational companies that can
leverage complementary technologies to advance this therapy for heart failure.
However, many fundamental challenges remain, including the adverse effects on
the vascular system and the right heart. Innovations in medicine, science, engineering,
and patient management can help to address these problems, and, if coordinated
across the community, will have the greatest potential to impact the field.
This GRC will be held in conjunction with the "Assisted Circulation" Gordon Research Seminar (GRS)
. Those interested in attending both meetings must submit an application for the GRS in addition to an application for the GRC. Refer to the associated GRS program page
for more information.
The topics and speakers for the conference sessions are displayed below (italics denote discussion leaders). The Conference Chair is currently developing their detailed program, which will include the complete meeting schedule, as well as the talk titles for all speakers. The detailed program will be available by February 25, 2017. Please check back for updates.
Direction of Mechanical Circulatory Support (MCS) – What We Have Learned Since REMATCH (Randomized Evaluation
of Mechanical Assistance for the Treatment of Congestive Heart Failure)
(Robin Bostic / Mandeep Mehra)
of Adverse Events That Are Limiting the Growth of Assisted
(Ulrich Jorde / David Farrar / George Wieselthaler / Lisa Baumann Kreuziger / Vig Kasirajan / Keyur Shah)
MCS Patient and Lifestyle Management
(Lynne Warner-Stevenson, Kartik Sundareswaran / Donna Mancini / Eldrin Lewis / Kathleen Grady / Nir Uriel)
Selecting and Managing the Right Patient for the Right Outcome
(Francis Pagani / Joseph Rogers / Stavros Drakos / Eduardo Rame)
The Future of Intelligent Pumping
(Victor Pretorius, Heinrich Schima / Francesco Moscato)
Academic Innovations: Myocardial Biomaterials and Tissue Engineering, Novel Battery Designs, Computational Models to Support FDA Submissions, Human Factors Engineering
(Steven Koenig, Salim Olia / Karen Christman / Amy Prieto / Amy Throckmorton)
Industry Innovations: New Advances in LVAD Pulsatility, Miniaturized MCS Devices, and Total Artificial Heart Design
(John Watson, Kurt Dasse / Richard Wampler)
The Global Future of MCS
(Timothy Baldwin / Changfu Wu / Robert Kormos / Tadashi Motomura)
Catalyzing the Next Steps to Solving Major MCS Challenges
(James Kirklin / James Antaki)